Company Search:
Advanced Search
Sponsored Links
Gilead Sciences, Inc. Company Snapshot
Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other companies in this sector in UNITED STATES : Biogen Inc (2019 sales of $14.38 billion of which 100% was Biopharmaceutical), Grifols SA ($5.70 billion of which 78% was Bioscience), and Amgen Inc. ($23.36 billion of which 22% was Enbrel).

Sales Analysis. Gilead Sciences reported sales of $22.45 billion for the year ending December of 2019. This represents a very small increase of 1.5% versus 2018, when the company's sales were $22.13 billion. Despite this increase, sales are still well below the level achieved in 2017, when Gilead Sciences reported sales of $26.11 billion. The sales level in 2019 was fairly close to the level five years ago: in 2014, Gilead Sciences had sales of $24.89 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Gilead Sciences, Inc.
  Stock Performance Chart for Gilead Sciences, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 62.25
(Figures in U.S. Dollars)
1 Week -4.3%   13 Weeks -4.6%  
4 Weeks -16.5%   52 Weeks -1.0%  
Gilead Sciences, Inc. Key Data:
  Ticker: GILD Country: United States
  Exchanges: NAS FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 22,449,000,000
(Year Ending Jan 2020).
Employees: 11,800
  Currency: U.S. Dollars Market Cap: 78,061,500,000
  Fiscal Yr Ends: December Shares Outstanding: 1,254,000,000
  Share Type: Common Closely Held Shares: 7,729,434
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.